|
National Stock Number(NSN): 6505-01-334-9468 (6505013349468, 013349468)
| NIIN: |
01-334-9468 |
Item Name: |
NITROGLYCERIN IN DEXTROSE INJECTION |
INC: |
46895
|
| FSC: |
6505
|
Assignment Date: |
Mar-05-1991 |
CRIT: |
X |
IIG: |
46895 |
| ISC: |
5 |
Date Standardized: |
Mar-05-1991 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9220 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
1A0696 |
0B4V2
|
BAXTER HEALTHCARE CORP |
H |
3 |
9 |
4 |
KX |
|
|
|
|
|
|
|
A90L124 |
66732
|
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMO-SA |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00338-1051-02 |
0B4V2
|
BAXTER HEALTHCARE CORP |
H |
5 |
9 |
4 |
KX |
|
B |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
K |
U |
1 |
A |
$288.48 |
PG |
|
C2201X- |
May-01-1998 |
H |
| DF |
S9M |
Y |
|
K |
U |
1 |
F |
$50.59 |
PG |
|
------- |
Nov-01-1997 |
H |
| DN |
S9M |
V |
|
K |
U |
1 |
N |
$50.59 |
PG |
|
9L----- |
Dec-01-1997 |
H |
| DS |
JDC |
L |
|
K |
U |
1 |
D |
$50.59 |
PG |
|
------- |
Oct-01-1994 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 12EA |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 12EA |
000 |
|
|
|
| DS |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
100.000 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE, GLASS |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
250.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
12 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
IN 5 PCT DEXTROSE |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,BAXTER HEALTHCARE CORP |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|